Breaking News

Alleged sexual misconduct stole one student’s passion for science; tech could improve pregnancy care for low-income patients

January 24, 2023
Lila, a medical student at Washington University in St. Louis, alleges a postdoctoral mentor coerced her into an unwanted sexual relationship.
Chloe Ellingson for STAT

STAT+ | 'I'm just disgusted': How alleged sexual misconduct stole one student's passion for academic science

"The passion I had coming in for science, it's not there at all," the M.D.-Ph.D. student said. "I'm just disgusted by academia."

By Jonathan Wosen


STAT+ | Amazon Pharmacy expands with new $5 monthly prescription service

Amazon is launching RxPass, a new prescription service that lets patients get eligible generic medications for a $5 monthly subscription.

By Mohana Ravindranath


STAT+ | Health systems have much higher prices, only marginally better quality, new study finds

A new JAMA study finds quality is only marginally better but prices are much higher when patients get care at health systems.

By Tara Bannow



Molly Ferguson for STAT

Technology could improve pregnancy care for low-income patients — if health systems can pay for it

Coverage policies vary widely by state, so the patients who most need these services can't always get them.

By Mohana Ravindranath


STAT+ | Doctors' group complains that 60 Minutes segment on Wegovy was really just an ad

A physician's group has filed a complaint with the FDA alleging a 60 Minutes segment about the Wegovy weight-loss drug was actually an ad.

By Ed Silverman


Predictive biomarkers could ease the exhaustive trial-and-error of antidepressants

In a new study, researchers are attempting to identify biomarkers that could predict which antidepressants will work best for patients.

By Theresa Gaffney


Adobe

Study of pancreatitis surgery patients finds steady decline in survival and need for better addiction support

The findings suggest that patients who have pancreatitis surgery also need years of support for problems like diabetes and addiction.

By Isabella Cueto


STAT+ | New results show Cassava's Alzheimer's drug has placebo-like efficacy

Cassava Sciences had long claimed that its experimental treatment for Alzheimer's disease was capable of improving the cognition of patients.

By Adam Feuerstein


Opinion: It's time to retire 'poor historian' from clinicians' vocabularies

The term "poor historian," used to designate someone who can't give a clear accounting of their illness or symptoms, needs to go.

By Steven Server and Samuel Schotland


STAT+ | Many pediatric drug study results were never posted to a U.S. government database

"If the results are not made public, those studies are of no help to anyone," said Diana Zuckerman of the National Center for Health Research

By Ed Silverman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments